Seite - (000208) - in Biomedical Chemistry: Current Trends and Developments

Vertes, R. P. and A. M. Crane (1997). Distribution, quantification, and morphological characteristics of serotonin-immunoreactive cells of the supralemniscal nucleus (B9) and pontomesencephalic reticular formation in the rat. Journal of Comparative Neurology, 378(3), 411-424. Vertes, R. P., W. J. Fortin, et al. (1999). Projections of the median raphe nucleus in the rat. Journal of Comparative Neurology, 407(4), 555-582. Volkow, N. D., J. S. Fowler, et al. (2002). Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiology of Learning & Memory, 78(3), 610-624. Voorn, P. (1988). The dopaminergic innervation of the striatum in th rat. Department of Anatomy and Embryology. Amsterdam, Vrije Universiteit, 175 p. Walker, R. H., C. Moore, et al. (2012). “Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat.” PloS one 7(3): e32919. Wang, D. D. and A. R. Kriegstein (2011). Blocking early GABA depolarization with bumetanide results in permanent alterations in cortical circuits and sensorimotor gating deficits. Cerebral cortex, 21(3), 574-587. Wasterlain, C. G., J. M. Bronstein, et al. (1992). Translocation and autophosphorylation of brain calmodulin kinase II in status epilepticus. Epilepsy Research. Supplement, 9, 231-238. Wasterlain, C. G., H. Liu, et al. (2009). Molecular basis of self-sustaining seizures and pharmacoresistance during status epilepticus: The receptor trafficking hypothesis revisited. Epilepsia, 50 Suppl 12, 16-18. Weinberger, D. R., K. F. Berman, et al. (1988). Mesocortical dopaminergic function and human cognition. Annual of the New york Academy of Sciences, 537, 330-338. Willner, P., A. S. Hale, et al. (2005). Dopaminergic mechanism of antidepressant action in depressed patients. Journal of Affective Disorders, 86(1), 37-45. Winder, D. G., R. E. Egli, et al. (2002). Synaptic plasticity in drug reward circuitry. Current Molecular Medicine, 2(7), 667-676. Woodward, D. J., J. Y. Chang, et al. (1999). Mesolimbic neuronal activity across behavioral states. Ann N Y Acad Sci, 877, 91-112. Wu, Y., D. Liu, et al. (2014). Neuronal networks and energy bursts in epilepsy. Neuroscience. Yadid, G., Y. Fraenkel, et al. (1998). Strychnine, glycine, and adrenomedullary secretion. Advances in Pharmacology, 42, 604-606. Yao, W. D., R. R. Gainetdinov, et al. (2004). Identification of PSD-95 as a regulator of dopamine- mediated synaptic and behavioral plasticity. Neuron, 41(4), 625-638. Ziemann, U., W. Paulus, et al. (2008). Consensus: Motor cortex plasticity protocols. Brain Stimulation, 1(3), 164-182. Zoghbi, H. Y. and H. T. Orr (2000). Glutamine repeats and neurodegeneration. Annual Review of Neuroscience, 23, 217-247. *Corresponding author: Teresa Summavielle: Addiction Biology Group, Instituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Rua Alfredo Allen, 208 | 4200-135 Porto,